Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD

Summary

The purpose of this study is to evaluate the effectiveness and safety of Daytrana® in the treatment of attention deficit hyperactivity disorder (ADHD) in adults who have abused stimulants in the past. Daytrana® is a stimulant medication that has been approved by the Food and Drug Administration for the treatment of ADHD in children over the age of 6 years old.

Timeline

Start

2007-04

Primary completion

2008-10

Completion

2009-02

Drugs

Indications